on 29 Dec 2023
Last Applicant/ Owned by
GLYSCEND INC.
Ste 250 600 Suffolk StreetLowell MA 01854-3643
US
Serial Number
2153063 filed on 8th Nov 2021
Trademark usage description
pharmaceutical preparations for the treatment of metabolic diseases including diabetes.11
2153063
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 236 on 14th Apr 2023 | Partial Withdrawal - Madrid Protocol |
Submitted for opposition 22 on 21st Mar 2023 | Search Recorded |
Submitted for opposition 20 on 21st Mar 2023 | Examiner's First Report |
Submitted for opposition 223 on 21st Mar 2023 | Total Provisional Refusal |
Submitted for opposition 256 on 10th Oct 2022 | Notification of Possible Opposition Sent |
Submitted for opposition 257 on 9th Dec 2021 | Designation Notification - Madrid Protocol |
Submitted for opposition 1 on 8th Dec 2021 | Created |
Submitted for opposition 31 on 8th Dec 2021 | Formalized |
Submitted for opposition 30 on 8th Nov 2021 | Filed |
Submitted for opposition 228 on 8th Nov 2021 | International Registration |